PDG3 ANTI-VEGF DRUGS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION - A SYSTEMATIC REVIEW OF THE IMPACT OF ANTI-VEGF THERAPY ON REDUCING BLINDNESS AND VISUAL IMPAIRMENT

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1017
https://www.valueinhealthjournal.com/article/S1098-3015(19)33395-9/fulltext
Title : PDG3 ANTI-VEGF DRUGS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION - A SYSTEMATIC REVIEW OF THE IMPACT OF ANTI-VEGF THERAPY ON REDUCING BLINDNESS AND VISUAL IMPAIRMENT
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33395-9&doi=10.1016/j.jval.2019.09.1017
First page :
Section Title :
Open access? : No
Section Order : 10897
Categories :
Tags :
Regions :
ViH Article Tags :